The field of cell and gene therapy (CGT) is undergoing a significant transformation, with a notable shift towards allogeneic platforms. Placing a spotlight on what has been deemed the ‘future […]
The post Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom: Recap of the Allogeneic Cell Therapies Summit 2023 appeared first on AllCells.
Allcells is a California-based company that procures and customizes primary cell products for the pharmaceutical, biotechnology, and medical device industries.